Speciality Medicines Limited
Niraj Rajnikant Shah added over 5.23% of Speciality Medicines during the quarter and now holds 6.23%, representing 5,47,000 shares, crossing the 5% disclosure threshold.
A pharmaceutical company engaged in marketing and distribution of speciality finished formulations across India. Incorporated in 2021, the company focuses on niche therapeutic areas and builds its business through strategic partnerships with established pharmaceutical manufacturers. Speciality Medi operates as a specialized distribution and marketing platform serving hospitals, clinics, and retail pharmacies with medicines targeting specific disease segments and patient populations in the Indian pharmaceutical sector.
An active trader in Indian small and SME cap stocks, typically building positions and trimming them over a matter of weeks rather than holding for the long run. Associated with Neil Finstock Private Limited, with a financial services background. Appears across a wide set of lightly traded names, often buying and selling the same stock within the same quarter.